VEGFR2/CD309 Protein

Produktnummer ABIN2132531

Recombinant VEGFR2/CD309-Protein exprimiert in Insect cells (Sf9).

Kurzübersicht für VEGFR2/CD309 Protein (ABIN2132531)

Target: VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Protein-Typ: Recombinant

Spezies: Human

Quelle: Insect cells (Sf9)

Reinheit: > 90 % pure

Produktdetails

Produktmerkmale: Purified recombinant Human VEGFR2 protein
Expression System: Sf-9 insect cells

Endotoxin-Niveau: < 0.1 ng per μg of sKDR

Anwendungsinformationen

Applikationshinweise: Each Investigator should determine their own optimal working dilution for specific applications.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Reconstitute in PBS or sterile water to a concentration of > 100 ng/mL.

Buffer: Supplied as a lyophilized powder.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: -20 °C

Informationen zur Lagerung: Ships ambient or refrigerated. Upon receipt store at -20 °C.

Antigendetails

Target: VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Andere Bezeichnung: VEGFR2

Hintergrund: Human soluble Endothelial Growth Factor Receptor-2 consists of all 7 extracellular domains, which contain all the information necessary for high affinity ligand binding. Endothelial cells express three different vascular endothelial growth factor (VEGF) receptors, belonging to the family of receptor tyrosine kinases (RTKs). They are named VEGFR-1 (Flt-1), VEGFR-2 (kDaR/Flk-1), VEGFR-3 (Flt-4).
Alternative Names: D1-7 protein, VEGF-R2 protein, Vascular Endothelial Growth Factor Receptor 2 protein, KDR protein

Molekulargewicht: 116 kDa

Pathways: RTK Signalweg, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling